Annual report pursuant to Section 13 and 15(d)

Organization and description of business (Details Narrative)

v3.21.2
Organization and description of business (Details Narrative) - USD ($)
1 Months Ended
May 31, 2021
Sep. 30, 2021
Sep. 30, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Cash   $ 27,622,067 $ 7,349,903
Merger Agreement [Member] | Spin Off Entity [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Payment made for spin-off transaction   $ 6,000,000.0  
License Agreement [Member] | New Life Therapeutics PTE LTD [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Proceeds from license fees $ 1,000,000.0    
License Agreement [Member] | New Life Therapeutics PTE LTD [Member] | Maximum [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Future milestone payments $ 20,000,000.0